天目药业 (600671)
Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co., Ltd.
K-Line Chart
No K-line data available
Company NameHangzhou Tianmu Mountain Pharmaceutical Co., Ltd.
Listing Date1993-08-23
Issue Price1RMB
Registered Capital12177.888510k RMB
Legal RepresentativeLiu Jiayong
Registered AddressNo. 18 Shangyang Road, Jinnan Street, Lin'an District, Hangzhou City, Zhejiang Province
IndustryTraditional Chinese Medicine II
Main BusinessManufacturing and sales of biopharmaceuticals, traditional Chinese patent medicines, Western medicines, health foods, electronic products, and machine-made paper, as well as commercial trade and stall rentals.
Company ProfileHangzhou Tianmu Mountain Pharmaceutical Co., Ltd. is located in Lin'an District, a western suburb of Hangzhou City, 38 kilometers from the provincial capital, Hangzhou. Lin'an District is a nationally designated 'National Forest City' and 'National Excellent Ecological Demonstration City.' Within its territory are two national nature reserves: 'Tianmu Mountain,' the largest primeval forest in East China, and 'Qingliang Peak.' The area boasts an elegant natural environment and is a picturesque Jiangnan city with clear waters and green mountains. The company's factory site features a beautiful environment and a rich cultural heritage.
Stock Details
1. Key Indicators
- Total Shares(W): 12177.89
- Circulating A-Shares(W): 12172.05
- Earnings Per Share(RMB): 0.1167
- Net Assets Per Share(RMB): 0.5468
- Operating Revenue(W RMB): 15894.04
- Total Profit(W RMB): 1000.12
- **Net Profit Attributable to Parent(W RMB) **: 1420.88
- Net Profit Growth Rate(%): 484.48
- Weighted Return on Equity(%): 23.8900
- Operating Cash Flow Per Share(RMB): -0.2530
- Undistributed Profit Per Share(RMB): -1.9885
- Capital Reserve Per Share(RMB): 1.3367
2. Main Business
The main business covers:
- Sales of pharmaceuticals and related healthcare products
3. Company Basic Information
- Company Name: Hangzhou Tianmu Mountain Pharmaceutical Co., Ltd.
- Listing Date: 1993-08-23
- Industry: Pharmaceutical Manufacturing
- Address: No. 18 Shangyang Road, Jinnan Street, Lin'an District, Hangzhou City, Zhejiang Province
- Website: https://www.hztmyy.com/
- Company Profile: The company's predecessor was Hangzhou Tianmu Mountain Pharmaceutical Factory, which underwent a joint-stock restructuring in 1989, initially converting the factory's net assets into 45,000 shares of corporate shares with a face value of 100 RMB and 20,000 individual shares. In June 1992, it implemented a standardized joint-stock restructuring, converting the net asset value appreciation into 40,000 shares, bringing the total shares to 10.50 million. After the initial public offering in February 1993 and the additional issuance of corporate shares and preferred shares of 18.90 million shares in May of the same year, the total number of shares at the time of listing was 50.40 million.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Qingdao Huilong Huaze Investment Co., Ltd. | General Legal Person | 3651.95 | 30.00 |
| 2 | Qingdao Yuanjia Medical Technology Co., Ltd. | General Legal Person | 1616.00 | 13.28 |
| 3 | Zhejiang Qingfeng Yuansheng Culture Co., Ltd. | General Legal Person | 518.18 | 4.26 |
| 4 | Hangzhou Yuedianrun Investment Management Partnership (Limited Partnership) | General Legal Person | 500.00 | 4.11 |
| 5 | Beijing Heyi Yingtong Asset Management Co., Ltd. - Heyi Huxuan Value No. 1 Private Securities Investment Fund | Private Securities Investment Fund | 71.72 | 0.59 |
| 6 | UBS AG | QFII | 55.76 | 0.46 |
5. Concept Sectors
- Micro-cap Stocks
- High Price-to-Book Ratio
- Delisting Risk Removal (Hat Removal)
- Long-Term No Dividends
- Shell Resource
- QFII New Entry
- Small Cap Non-Margin
- Small Cap State-Owned Enterprise
- Micro-cap Selection
- Private Placement New Entry
Remarks
- Data update date: 2025-11-03
- Data source: Public Market Information